KalVista Pharmaceuticals Inc (KALV)
9.325
+0.36
(+4.07%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Total Liabilities (Quarterly): 27.40M for July 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 27.40M |
| April 30, 2024 | 28.82M |
| January 31, 2024 | 25.38M |
| October 31, 2023 | 24.30M |
| July 31, 2023 | 21.00M |
| April 30, 2023 | 22.18M |
| January 31, 2023 | 19.03M |
| October 31, 2022 | 19.02M |
| July 31, 2022 | 17.75M |
| April 30, 2022 | 18.79M |
| January 31, 2022 | 17.12M |
| October 31, 2021 | 16.34M |
| July 31, 2021 | 14.70M |
| April 30, 2021 | 14.82M |
| January 31, 2021 | 7.641M |
| October 31, 2020 | 10.47M |
| July 31, 2020 | 9.467M |
| April 30, 2020 | 8.777M |
| January 31, 2020 | 13.19M |
| October 31, 2019 | 14.28M |
| July 31, 2019 | 18.02M |
| Date | Value |
|---|---|
| April 30, 2019 | 21.39M |
| January 31, 2019 | 22.49M |
| October 31, 2018 | 25.61M |
| July 31, 2018 | 31.37M |
| April 30, 2018 | 34.14M |
| January 31, 2018 | 38.09M |
| October 31, 2017 | 3.662M |
| July 31, 2017 | 4.05M |
| April 30, 2017 | 3.018M |
| January 31, 2017 | 3.201M |
| September 30, 2016 | 1.926M |
| June 30, 2016 | 1.971M |
| March 31, 2016 | 6.604M |
| December 31, 2015 | 7.481M |
| September 30, 2015 | 7.458M |
| June 30, 2015 | 8.274M |
| March 31, 2015 | 56.68M |
| December 31, 2014 | 50.82M |
| September 30, 2014 | 50.50M |
| December 31, 2013 | 43.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.641M
Minimum
Jan 2021
28.82M
Maximum
Apr 2024
17.69M
Average
17.75M
Median
Jul 2022
Total Liabilities (Quarterly) Benchmarks
| Nuwellis Inc | 3.549M |
| Perspective Therapeutics Inc | 62.68M |
| Electromed Inc | 7.427M |
| Xtant Medical Holdings Inc | 53.16M |
| Myomo Inc | 7.020M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.20M |
| Shareholders Equity (Quarterly) | 172.80M |